We are live on ! Find out more
ECP

Empyrean Capital Partners Portfolio holdings

AUM $3.07B
1-Year Est. Return 34.24%
This Fund
S&P 500
This Quarter Est. Return
+7.78%
1 Year Est. Return
+34.24%
3 Year Est. Return
+104.05%
5 Year Est. Return
+133.06%
10 Year Est. Return
+500.1%
AUM
$2.82B
AUM Growth
+$626M
Cap. Flow
+$451M
Cap. Flow %
16.02%
Top 10 Hldgs %
62.79%
Holding
81
New
13
Increased
8
Reduced
5
Closed
22

Top Buys

Rank Stock Value
1
MPC icon
Marathon Petroleum
MPC
+$77M
2
FTAI icon
FTAI Aviation
FTAI
+$65.5M
3
UNH icon
UnitedHealth
UNH
+$61.3M
4
CAH icon
Cardinal Health
CAH
+$48.3M
5
CVS icon
CVS Health
CVS
+$38.4M

Sector Composition

Rank Sector Weight
1 Energy 16.94%
2 Industrials 9.76%
3 Healthcare 9.22%
4 Financials 6.29%
5 Utilities 5.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HYG icon
1
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
$458M 16.25%
+5,800,000
New +$460M
IWM icon
2
PUT
iShares Russell 2000 ETF
IWM
$79.1B
$366M 13%
+1,835,000
New +$398M
HES
3
DELISTED
Hess
HES
$192M 6.8%
1,199,000
SHEL icon
4
Shell
SHEL
$244B
$169M 5.99%
2,300,000
AER icon
5
AerCap
AER
$23.4B
$141M 5.02%
1,382,000
-218,000
-14% -$21.6M
SPY icon
6
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$771B
$123M 4.37%
+220,000
New +$129M
CVS icon
7
CVS Health
CVS
$135B
$104M 3.68%
1,531,000
+641,000
+72% +$38.4M
MPC icon
8
Marathon Petroleum
MPC
$90.1B
$75.8M 2.69%
+520,500
New +$77M
TXNM
9
TXNM Energy Inc
TXNM
$6.39B
$75.1M 2.67%
1,404,554
PCG icon
10
PG&E
PCG
$39B
$65.3M 2.32%
3,800,000
-2,097,000
-36% -$34.8M
APG icon
11
APi Group
APG
$16.7B
$64.4M 2.29%
2,700,000
UNH icon
12
UnitedHealth
UNH
$382B
$62.9M 2.23%
+120,000
New +$61.3M
FTAI icon
13
FTAI Aviation
FTAI
$20.2B
$61.5M 2.19%
+554,320
New +$65.5M
OPTU
14
Optimum Communications Inc
OPTU
$298M
$53.5M 1.9%
20,100,000
+2,400,000
+14% +$6.49M
NMRK icon
15
Newmark Group
NMRK
$2.64B
$53.1M 1.88%
4,360,150
CAH icon
16
Cardinal Health
CAH
$53.7B
$52.2M 1.85%
+379,000
New +$48.3M
ENVA icon
17
Enova International
ENVA
$6.09B
$49.5M 1.76%
512,800
+50,000
+11% +$5.15M
AAMI
18
Acadian Asset Management
AAMI
$2.88B
$48.6M 1.73%
1,880,634
ALIT icon
19
Alight
ALIT
$534M
$44.5M 1.58%
375,000
-75,000
-17% -$9.87M
VTOL icon
20
Bristow Group
VTOL
$1.33B
$35.7M 1.27%
1,130,000
+50,000
+5% +$1.72M
CCIX
21
Churchill Capital Corp IX
CCIX
$31.3M 1.11%
2,900,000
ITCI
22
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$30.1M 1.07%
+228,000
New +$28.4M
DFS
23
DELISTED
Discover Financial Services
DFS
$28.7M 1.02%
168,000
-415,000
-71% -$75.9M
LBRDK icon
24
Liberty Broadband Class C
LBRDK
$4.89B
$27.3M 0.97%
320,561
NN icon
25
NextNav
NN
$1.79B
$20.5M 0.73%
1,685,000
+300,000
+22% +$3.62M

Similar funds

Empyrean Capital Partners's Q1 2025 Portfolio in Review

As of Q1 2025, Empyrean Capital Partners held 81 positions worth $2.82B, up 29% from $2.19B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Empyrean Capital Partners deployed $451M of net new capital in Q1 2025, opening 13 new positions and adding to 8 existing holdings. Its largest new stake was Marathon Petroleum: 520,500 shares worth $75.8M.

By sector, the portfolio is most concentrated in Energy at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Discover Financial Services, an estimated $75.9M trimmed.

  • Empyrean Capital Partners's largest Q1 2025 buy was Marathon Petroleum: 520,500 shares worth $75.8M.
  • Empyrean Capital Partners added most to CVS Health in Q1 2025, an estimated $38.4M increase.
  • Empyrean Capital Partners's biggest Q1 2025 reduction was Discover Financial Services, cutting an estimated $75.9M.
  • Empyrean Capital Partners fully exited Dominion Energy in Q1 2025, selling an estimated $84.7M.
  • Empyrean Capital Partners's ten largest holdings make up 63% of its $2.82B portfolio in Q1 2025.
  • Empyrean Capital Partners opened 13 new positions and closed 22 in Q1 2025.
  • Empyrean Capital Partners's portfolio value rose 29% quarter-over-quarter to $2.82B.

Based on Empyrean Capital Partners's 13F filing for Q1 2025, filed 15 May 2025.